Testing fungal biomarkers for directing antifungal therapy for invasive fungal disease in patients with high-risk haematological malignancies in a University Teaching Hospital: a cost benefit analysis

被引：0
|
作者：
Perera, N. [1 ]
Lim, F. H. [1 ]
Saibudeen, A. [1 ]
Hodgson, K. [1 ]
机构：
[1] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
来源：
MYCOSES | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P126
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [21] Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
    Barnes, R. A.
    White, P. L.
    Bygrave, C.
    Evans, N.
    Healy, B.
    Kell, J.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (01) : 64 - 69
  • [22] Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
    Shi, Changcheng
    Ye, Jian
    Xie, Yaping
    Dong, Rong
    Jin, Weizhong
    Wang, Linling
    Fang, Yingying
    Shan, Qiyuan
    Lin, Nengming
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [23] Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study
    Wang, Ling
    Wang, Ying
    Hu, Jiong
    Sun, Yuqian
    Huang, He
    Chen, Jing
    Li, Jianyong
    Ma, Jun
    Li, Juan
    Liang, Yingmin
    Wang, Jianmin
    Li, Yan
    Yu, Kang
    Hu, Jianda
    Jin, Jie
    Wang, Chun
    Wu, Depei
    Xiao, Yang
    Huang, Xiaojun
    FRONTIERS OF MEDICINE, 2019, 13 (03) : 365 - 377
  • [24] Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study
    Ling Wang
    Ying Wang
    Jiong Hu
    Yuqian Sun
    He Huang
    Jing Chen
    Jianyong Li
    Jun Ma
    Juan Li
    Yingmin Liang
    Jianmin Wang
    Yan Li
    Kang Yu
    Jianda Hu
    Jie Jin
    Chun Wang
    Depei Wu
    Yang Xiao
    Xiaojun Huang
    Frontiers of Medicine, 2019, 13 : 365 - 377
  • [25] Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
    Santiago Grau
    Rafael de la Cámara
    Francisco J Sabater
    Isidro Jarque
    Enric Carreras
    Miguel A Casado
    Miguel A Sanz
    BMC Infectious Diseases, 12
  • [26] Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
    Maertens, J
    Theunissen, K
    Verhoef, G
    Verschakelen, J
    Lagrou, K
    Verbeken, E
    Wilmer, A
    Verhaegen, J
    Boogaerts, M
    Van Eldere, J
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) : 1242 - 1250
  • [27] Invasive Fungal Infections in Pediatric Patients with High-Risk Acute Lymphoblastic Leukemia during Initial Phases of Therapy: A Retrospective Evaluation
    Shliakhtsitsava, Ksenya
    Grapsy, Jillian
    Hsu, Christina
    Almatrafi, Mohammad
    Sebert, Michael
    Pacheco, Martha
    Huang, Rong
    Sue, Paul
    BLOOD, 2020, 136
  • [28] Cost-Effectiveness of Posaconazole Compared with Standard Azole Therapy for Prevention of Invasive Fungal Infections in Patients at High Risk in Switzerland
    Greiner, Roger-Axel
    Meier, Yvonne
    Papadopoulos, George
    O'Sullivan, Amy K.
    Imhof, Alexander
    ONCOLOGY, 2010, 78 (3-4) : 172 - 180
  • [29] Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
    Grau, Santiago
    de la Camara, Rafael
    Sabater, Francisco J.
    Jarque, Isidro
    Carreras, Enric
    Casado, Miguel A.
    Sanz, Miguel A.
    BMC INFECTIOUS DISEASES, 2012, 12
  • [30] COST-EFFECTIVENESS OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE IN THE PREVENTION OF INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN SINGAPORE
    Fust, K.
    Weinstein, M. C.
    Gomez-Rey, G.
    Xie, Y.
    Hsu, T. Y.
    Pawar, V
    Hsu, L. Y.
    Tan, B. H.
    O'Sullivan, A. K.
    VALUE IN HEALTH, 2013, 16 (03) : A138 - A139
12345